StonvexLoading…
StonvexCore line items from HR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $28.21M | $19.16M | $17.45M | $13.71M |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $-246.07M | $-654.49M | $-278.26M | $40.90M |
EPS (Diluted) | $-0.71 | $-1.81 | $-0.74 | $0.15 |
Total Assets | $9.21B | $10.65B | $12.64B | $13.85B |
Total Liabilities | $4.53B | $5.35B | $5.71B | $6.17B |
Cash & Equivalents | $26.17M | $68.92M | $25.70M | $60.96M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 351.60M | 350.53M | 380.96M | 380.59M |